Flatiron Health has announced a partnership with NRG Oncology to implement the electronic health record (EHR) to electronic data capture (EDC) connector, Flatiron Clinical Pipe, in a multi-centre NRG trial.
This technology is expected to enhance efficiency and minimise the time required for entering clinical trial data.
Go deeper with GlobalData
Flatiron Clinical Pipe is tailored to “streamline” data management and expedite the timelines of the trial.
In addition to the deployment, the two entities will undertake a correlative trial to evaluate the efficiency of the pipe against traditional methods of data entry.
According to research, it is indicated that the technology enables transfer of thousands of data points in a short span of time, decreasing the time spent on entering the data throughout a trial.
Minimising the time required for administrative work enables providers to dedicate additional time to the subjects, enhancing the overall care experience.
Flatiron Clinical Pipe claims to minimise queries and expedite the timelines for data cleaning.
The data captured and transferred by this technology is a direct reflection of the original EMR/EHR information, which removes the necessity for source data verification (SDV).
This feature is expected to bring about “transformative” efficiency and productivity improvements for site coordinators, monitors and other trial team members.
Flatiron Health clinical research general manager Alex Deyle said: “Collaborating with NRG Oncology, a leading research consortium within the National Clinical Trials Network, is an incredible opportunity to create a new trial experience—unlocking higher data quality and more efficient data acquisition with Flatiron Clinical Pipe.
“By putting our cutting-edge technology in the hands of more research teams, Flatiron and NRG will enhance our ongoing efforts to improve efficiency and reduce time and effort of study data capture, ultimately accelerating evidence generation and improvements in care for people with cancer.”
